<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20190208//EN"
       "JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.4" xml:lang="en">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">Acta biomedica scientifica</journal-id>
   <journal-title-group>
    <journal-title xml:lang="en">Acta biomedica scientifica</journal-title>
    <trans-title-group xml:lang="ru">
     <trans-title>Acta biomedica scientifica</trans-title>
    </trans-title-group>
   </journal-title-group>
   <issn publication-format="print">2541-9420</issn>
   <issn publication-format="online">2587-9596</issn>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="publisher-id">14208</article-id>
   <article-id pub-id-type="doi">10.12737/23000</article-id>
   <article-categories>
    <subj-group subj-group-type="toc-heading" xml:lang="ru">
     <subject>Экономика и менеджмент в здравоохранении</subject>
    </subj-group>
    <subj-group subj-group-type="toc-heading" xml:lang="en">
     <subject>Healthcare Management and Economics</subject>
    </subj-group>
    <subj-group>
     <subject>Экономика и менеджмент в здравоохранении</subject>
    </subj-group>
   </article-categories>
   <title-group>
    <article-title xml:lang="en">CLINICAL TRIALS IN IRKUTSK SCIENTIFIC CENTER OF SURGERY AND TRAUMATOLOGY: RESULTS AND PROSPECTS</article-title>
    <trans-title-group xml:lang="ru">
     <trans-title>КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ В ИНЦХТ: ИТОГИ И ПЕРСПЕКТИВЫ</trans-title>
    </trans-title-group>
   </title-group>
   <contrib-group content-type="authors">
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Демкова </surname>
       <given-names>Ольга  Васильевна</given-names>
      </name>
      <name xml:lang="en">
       <surname>Demkova </surname>
       <given-names>Olga  Васильевна</given-names>
      </name>
     </name-alternatives>
     <email>demkova-olga@mail.ru</email>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Апарцин </surname>
       <given-names>Константин  Анатольевич </given-names>
      </name>
      <name xml:lang="en">
       <surname>Apartsin </surname>
       <given-names>Konstantin  Анатольевич </given-names>
      </name>
     </name-alternatives>
     <email>dr.apartsin@yahoo.com</email>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Горохова</surname>
       <given-names> Анна  Владиславовна</given-names>
      </name>
      <name xml:lang="en">
       <surname>Gorokhova</surname>
       <given-names> Anna  Владиславовна</given-names>
      </name>
     </name-alternatives>
     <email>av.vybivantseva@gmail.com</email>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
   </contrib-group>
   <aff-alternatives id="aff-1">
    <aff>
     <institution xml:lang="ru">Иркутская ордена «Знак Почёта» областная клиническая больница</institution>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Иркутская ордена «Знак Почёта» областная клиническая больница</institution>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <pub-date publication-format="print" date-type="pub" iso-8601-date="2016-12-02T00:00:00+03:00">
    <day>02</day>
    <month>12</month>
    <year>2016</year>
   </pub-date>
   <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2016-12-02T00:00:00+03:00">
    <day>02</day>
    <month>12</month>
    <year>2016</year>
   </pub-date>
   <volume>1</volume>
   <issue>4</issue>
   <fpage>129</fpage>
   <lpage>134</lpage>
   <self-uri xlink:href="https://zh-szf.ru/en/nauka/article/14208/view">https://zh-szf.ru/en/nauka/article/14208/view</self-uri>
   <abstract xml:lang="ru">
    <p>Проанализирован опыт участия ИНЦХТ в международных многоцентровых клинических исследованиях(ММКИ), рассмотрены предпосылки к созданию и двухлетние результаты работы лаборатории клинических исследований. Охарактеризована методология проведения ММКИ и р ассмотрены результаты ее трансляции в практику Иркутской ордена «Знак почёта» областной больницы и Больницы Иркутского научного центра СО РАН. Рассмотрены текущие результаты наблюдательных исследований и перспективы проведения клинической апробации в ИНЦХТ разработанных медицинских технологий. Показана роль клинических исследований по Национальному стандарту «Надлежащая клиническая практика» как методологическая основа деятельности научно-исследовательской учреждения прикладного профиля.</p>
   </abstract>
   <trans-abstract xml:lang="en">
    <p>Clinical drug trials in Irkutsk Scientific Center of Surgery and Traumatology began in 2005. In 2013, the laboratory of clinical trials was established in the science department of clinical surgery. We analyzed the experience of Irkutsk Scientific Center of Surgery and Traumatology in international multicentre trials. Participation in international mul-ticentre trials allows the Irkutsk Scientific Center of Surgery and Traumatology to get affiliated with the publications in first quartile scientific journals. The experience of the laboratory in clinical trials is projected into practical work of other institutes – Hospital of Irkutsk Scientific Center SB RAS and Irkutsk Regional Clinical Hospital. The important objectives of the laboratory of clinical trials are developing the protocols, performing drug clinical trials and medical device clinical trials. The laboratory carries out admission of patients for observational trial PROTOCOL. One of the fields of work of the laboratory is the prospect of clinical testing of developed clinical technologies.</p>
   </trans-abstract>
   <kwd-group xml:lang="ru">
    <kwd>международные многоцентровые клинические исследования</kwd>
    <kwd>клинические исследования лекарственных средств</kwd>
    <kwd>лаборатория клинических исследований</kwd>
    <kwd>клиническая апроба-ция</kwd>
    <kwd>наблюдательные исследования</kwd>
   </kwd-group>
   <kwd-group xml:lang="en">
    <kwd>international multicentre trial</kwd>
    <kwd>drug clinical trials</kwd>
    <kwd>laboratory of clinical trials</kwd>
    <kwd>clinical testing</kwd>
    <kwd>observational trial</kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <p></p>
 </body>
 <back>
  <ref-list>
   <ref id="B1">
    <label>1.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">ЗеленскаяЕ.М., СубботовскаяА.И., Ганю-ковВ.И., КочергинН.А., БарбаричВ.Б., СараеваН.О., ВыбиванцеваА.В., АпарцинК.А., ЛифшицГ.И. Иссле-дование «ПРОТОКОЛ»: предварительные результаты в рамках проекта //Российский кардиологический журнал. - 2015. - No10. - С.75-80.</mixed-citation>
     <mixed-citation xml:lang="en">ZelenskayaEM, SubbotovskayaAI, GanyukovVI, KocherginNA, BarbarichVB, SarayevaNO, Vybi-vantsevaAV, ApartsinKA, LifshitsGI (2015). “PROTOCOL” trial: preliminary results of the project [Issledovanie «PROTOKOL»:  predvaritel’nye rezul’taty v ramkakh proekta]. Rossiyskiy kardiologicheskiy zhurnal, (10), 75-80</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B2">
    <label>2.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">ЛифшицГ.И., АпарцинК.А. Проспективное мно-гоцентровое наблюдательное исследование ПРОТО-КОЛ: Персонализированная терапия клопидогрелом при стентировании по поводу острого коронарного синдрома с учётом генетических полиморфизмов //Ка   чественная клиническая практика. - 2015. - No1. - С.78-86.</mixed-citation>
     <mixed-citation xml:lang="en">LifshitsGI, ApartsinKA (2015). Prospective, mul-ticenter observational study PROTOCOL: Personalized therapy with Clopidogrel after stenting at acute coro-nary syndrome with account of genetic polymorphisms [Prospektivnoe mnogotsentrovoe nablyudatel’noe issledovanie PROTOKOL: Personalizirovannaya terapiya klopidogrelom pri stentirovanii po povodu ostrogo koronarnogo sindroma s uchetom geneticheskikh polimorfizmov]. Kachestvennaya klinicheskaya praktika, (1), 78-86.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B3">
    <label>3.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">ЛифшицГ.И., КохН.В., АпарцинК.А. Создание портативного прибора для мультипараметрического контроля антитромботической терапии с учётом ге-нетических полиморфизмов //Персонализированная медицина и глобальное здоровье: Матер. междунар. конф. (Астана, Казахстан, 13-14мая 2015 г.). - 2015.- С.59-60.</mixed-citation>
     <mixed-citation xml:lang="en">LifshitsGI, KokhNV, ApartsinKA (2015). Develop-ment of portable device for multiparameter monitor-ing of antithrombotic therapy with account of genetic polymorphisms [Sozdanie portativnogo pribora dlya mul’tiparametricheskogo kontrolya antitromboticheskoy terapii s uchetom geneticheskikh polimorfizmov]. Person  -alizirovannaya meditsina i global’noe zdorov’e: Materialy mezhdunarodnoy konferentsii (Astana, Kazakhstan, 13-14 maya 2015 g.), 59-60.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B4">
    <label>4.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Надлежащая клиническая практика: Нацио-нальный стандарт Российской Федерации [Электрон-ный ресурс]. - Режим доступа: http://acto-russia.org/index.php?option=com_content&amp;amp;task=view&amp;amp;id=17 (дата обращения 19.05.2016).</mixed-citation>
     <mixed-citation xml:lang="en">Good Clinical Practice: National Standard of the Rus-sian Federation [Nadlezhashchaya klinicheskaya praktika: Natsional’nyy standart Rossiyskoy Federatsii]. Available at: http://acto-russia.org/index.php?option=com_con-tent&amp;amp;task=view&amp;amp;id=17 (Accessed May 19, 2016)</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B5">
    <label>5.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Об утверждении Положения об организации клинической апробации методов профилактики, диагностики, лечения и реабилитации и оказания медицинской помощи в рамках клинической апроба-ции методов профилактики, диагностики, лечения и реабилитации (в том числе порядка направления па-циентов для оказания такой медицинской помощи), типовой формы протокола клинической апробации методов профилактики, диагностики, лечения и реабилитации: Приказ Министерства здравоохра-нения РФ от 10.07.2015г. No433н. - Режим доступа: https://www.rosminzdrav.ru/documents/9211-prikaz-ministerstva-zdravoohraneniya-rf-ot-10-iyulya-2015-g-433n-ob-utverzhdenii-polozheniya-ob-organizatsii-klinicheskoy-aprobatsii-metodov-profilaktiki-diagnostiki-lecheniya-i-reabilitatsii-i-okazaniya-meditsinsko (дата обращения 19.05.2016).</mixed-citation>
     <mixed-citation xml:lang="en">Concerning approval of the Regulation on organi-zation of clinical testing of the methods of prevention,diagnostics, treatment and rehabilitation and the de-livery of health care in the course of clinical testing of the methods of prevention, diagnostics, treatment and rehabilitation (including procedure of referral of the patients to the health care), standard form of clinical testing of the methods of prevention, diagnostics, treat-ment and rehabilitation: Order of the Ministry of Health of the Russian Federation d.d. July 10, 2016 N433n [Ob utverzhdenii Polozheniya ob organizatsii klinicheskoy aprobatsii metodov profilaktiki, diagnostiki, lecheniya i reabilitatsii i okazaniya meditsinskoy pomoshchi v ramkakh klinicheskoy aprobatsii metodov profilaktiki, di-agnostiki, lecheniya i reabilitatsii (v tom chisle poryadka napravleniya patsientov dlya okazaniya takoy meditsin-skoy pomoshchi), tipovoy formy protokola klinicheskoy aprobatsii metodov profilaktiki, diagnostiki, lecheniya i reabilitatsii: Prikaz Ministerstva zdravookhraneniya RF ot 10.07.2015 g. No433n]. Available at: https://www.rosminzdrav.ru/documents/9211-prikaz-ministerst-va-zdravoohraneniya-rf-ot-10-iyulya-2015-g-433n-ob-utverzhdenii-polozheniya-ob-organizatsii-kliniches-koy-aprobatsii-metodov-profilaktiki-diagnostiki-lech-eniya-i-reabilitatsii-i-okazaniya-meditsinsko (Accessed May 19, 2016).</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B6">
    <label>6.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">Alprostadil in Peripheral Arterial Occlusive Disease (PAOD) Stage IV (2016). Available at: https://clinicaltrials.gov/ct2/show/study/NCT00596752?term=ESPECIAL&amp;amp;rank=2&amp;amp;sect=X01256 (Accessed May 19, 2016).</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B7">
    <label>7.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">DecoususH, PrandoniP, MismettiP, BauersachsR, BodZ, BrennerB, LaporteS, MatyasL, MiddeldorpS, SokurenkoG, LeizoroviczA (2010). Fondaparinux for the treatment of superficial-vein thrombosis in the legs. N. Engl. J. Med., 363(13), 1222-1232.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B8">
    <label>8.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">DecoususH, PrandoniP, MismettiP, BauersachsR, BodZ, BrennerB, LaporteS, MatyasL, MiddeldorpS, SokurenkoG, LeizoroviczA (2013). Edoxaban versus Warfarin for the treatment of symptomatic venous throm-boembolism. N. Engl. J. Med., 369(15), 1406-1415.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B9">
    <label>9.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">KalliomäkiJ, AttalN, JonzonB, BachF, HuizarK, RatcliffeS, ErikssonB, JaneckiM, DanilovA, BouhassiraD (2013). A randomized, double-blind, placebo-controlled trial of a chemokine receptor 2 (CCR2) antagonist in post-traumatic neuralgia. Pain, 154(5),761-767.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B10">
    <label>10.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">O’DonoghueM, GlaserR, CavenderM, AylwardP, BonacaM, BudajA, DaviesR, DellborgM, FoxK, GutierrezJ, HammC, KissR, KovarF, KuderJ, ImK, LeporeJ, Lopez-SendonJ, OphuisT, ParkhomenkoA, ShannonJ, SpinarJ, TanguayJ, RudaM, StegP, TherouxP, WiviottS, LawsI, SabatineM, MorrowD (2016). Effect of Losmapimod on cardiovascular outcomes in patients hospitalized with acute myocardial. JAMA, 315(15), 1591.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B11">
    <label>11.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">PrandoniP, CasigliaE, TikhonoffV, Leizo-roviczA, DecoususH (2011). The risk of subsequent cancer and arterial cardiovascular events in patients with superficial vein thrombosis in the legs. Blood, 118(17), 4719-4722.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B12">
    <label>12.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">SamamaC, LecoulesN, KierzekG, ClaessensY, RiouB, RosencherN, MismettiP, SautetA, BarrellierM, ApartsinK, JonasM, CaeiroJ, van der VeenA, RoyP (2013). Comparison of fondaparinux with low-molec-ular-weight heparin for VTE prevention in patients requiring rigid or semi-rigid immobilization for isolated non-surgical below-knee injury. J. Thromb. Haemost, 11(10), 1833-1843.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B13">
    <label>13.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">VybivantsevaAV  , DemkovaOV, KoryakinaLB, AndreevaEO, SaraevaN O, LifshitsG I, ApartsinKA   (2015). Impact of preanalytical delay on results of light trans-mittance aggregometry in STEMI patients. J. Thromb. Haemost, 13 (Suppl.2), 283.</mixed-citation>
    </citation-alternatives>
   </ref>
  </ref-list>
 </back>
</article>
